
About Orochem
Orochem is a Healthcare company based in Naperville (United States) founded in 1996. It operates as a products for biomolecular separation and purification are developed and manufactured. The company has 21 employees. Its Indian entity Orochem (India) Private Limited reported revenue of βΉ8.15 Cr. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Almac Group, Seqens, Asymchem, Aurobindo Pharma and Indoco Remedies and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Orochem develops and manufactures products for biomolecular separation and purification for industrial and research applications. The company was established in 1996 to manufacture products for bioanalysis, drug discovery, genomics and proteomics applications involving separation and purification of biomolecules. The company has a sizeable, and growing portfolio of products covering bioanalytical sample preparation and analysis, chromatography, simulated moving bed chromatography for purification of biochemicals and organic compounds, and proteomics. The company also manufactures positive pressure processors, vacuum manifolds and robotic liquid handling systems for laboratory automation and high-throughput lab processes. In 2006, Orochem acquired Column Engineering Inc to provide full-service silica manufacturing for analytical and preparatory chromatography. The company also offers CMO services for industrial scale purification of APIs, nutritional supplements, fatty acids, and speciality sugars.
- Headquarters Naperville, United States
- Employees 21
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website orochem.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Orochem (India) Private Limited
- Date of Incorporation 23 Nov, 2000
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹8.15 Cr
FY 2025 · +2% YoY
- Net Profit₹7.8 Lakh
FY 2025 · 1% margin
- EBITDA₹60 Lakh
FY 2025 · 7% margin
- Latest Funding Round$349.64K (USD), Grant
Sep 2020
- Investors
- Employee Count21
Associated legal entities of Orochem
Orochem operates through Orochem (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Orochem (India) Private Limited CIN U24231MH2000PTC129723 | Active | 23 Nov 2000 | Navi Mumbai, Maharashtra | ₹8.2 Cr | 21 | 5 | View details |
Apps and channels of Orochem
its YouTube channel orochemtech has 151 subscribers and 11 videos.
Videos from Orochem
The most watched videos on Orochem's YouTube channel, orochemtech (151 subscribers). Click a video to play it here.
More on orochemtech.
Funding Insights of Orochem
- Total Rounds 2
- Last Round Grant β $349,643
- First Round $225,000
(Jul 2016)
- Investors Count 1
All 2 funding rounds of Orochem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Orochem
Orochem has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Orochem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Orochem (India) Private Limited (Orochem)
Orochem (India) Private Limited is the primary company behind Orochem. The board of Orochem (India) Private Limited currently have 5 directors; the longest-serving is Vedbhushan Dharambir Gulati, appointed in 2000. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vedbhushan Dharambir Gulati DIN 01462944 | Director | 23 Nov 2000 | 25 yrs 10 mo | Orochem (India) Private Limited |
| Anil Rajaram Oroskar DIN 01457422 | Director | 23 Nov 2000 | 25 yrs 10 mo | Orochem (India) Private Limited |
| Subhash Rajaram Oroskar DIN 01461117 | Director | 23 Nov 2000 | 25 yrs 10 mo | Orochem (India) Private Limited |
| Sudha Neelkamal Tandon DIN 01863713 | Director | 23 Nov 2000 | 25 yrs 10 mo | Orochem (India) Private Limited |
| Asha A Oroskar DIN 01863608 | Director | 21 Jan 2008 | 18 yrs 8 mo | Orochem (India) Private Limited |
People of Orochem
5 people are tracked at Orochem (3 in leadership, 2 in team); the tracked headcount is 21.
| Name | Role | Group |
|---|---|---|
| President & CEO | Leadership | |
Ved Gulati | Operation Director | Leadership |
| CTO | Leadership | |
Hitesh Kshatriya | National Sales Manager | Team |
Xuejun Zang | Principal Scientist And Lead Of Technical Support | Team |
Complete people profiles for Orochem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Orochem
Figures of Orochem (India) Private Limited, the primary company behind Orochem, for FY 2025. Revenue was ₹8.15 Cr (+2% year on year). Net profit was ₹7.8 Lakh (1% margin). EBITDA was ₹60 Lakh (7% margin). Revenue has grown at a compounded annual rate of +7% over three years and +5% over five years.
- ₹8.15 CrRevenue · FY 2025 · +2% YoY
- ₹7.8 LakhNet profit · 1% margin
- ₹60 LakhEBITDA · 7% margin
- ₹13.9 LakhPaid-up capital
- 21Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Orochem (India) Private Limited are on its company page.
Detailed financial statements for Orochem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Orochem
3 dated milestones of Orochem across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Orochem is founded.
- Funding First funding round of $225K.
- Funding Latest funding round, Grant, of $350K.
Competitors of Orochem
Orochem has 9 listed competitors in our database, 3 of them funded. They include Almac Group, Seqens, Asymchem, Aurobindo Pharma and Indoco Remedies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| almacgroup.com | 2001 | Craigavon, United Kingdom | $338.8M | 2,109 | Integrated CDMO services for biopharma R&D and manufacturing are offered. | |
| seqens.com | 2003 | Ecully, France | – | 44 | Contract manufacturing services for small molecules and peptides are provided. | |
| asymchem.com | 1995 | Morrisville, United States | – | 48 | APIs and peptides are developed and manufactured by Asymchem. | |
| aurobindo.com | 1986 | Hyderabad, India | – | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. | |
| indoco.com | 1947 | Mumbai, India | – | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | |
| concordbiotech.com | 2000 | Ahmedabad, India | – | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | |
| aptuit.com | 2004 | Greenwich, United States | $14.23M | – | Contract research and development services for small molecules are offered. | |
| pharm-int.com | 1994 | Hunt Valley, United States | – | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. | |
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development |
Detailed competitors of Orochem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Orochem
The website of Orochem (orochem.com) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 126.2% vs previous month
Websites whose visitors overlap most with Orochem. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
enio1947.tripod.com | enio1947.tripod.com | 100% | – | – | β |
school.3xy.com.cn | school.3xy.com.cn | 47% | – | – | β |
| nuttyscientists.com | 46% | 9.7K | #2,098,572 | View details | |
| famousscientists.org | 46% | – | #475,635 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Orochem (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Orochem
Orochem was founded in 1996 and raised its 1st funding round 20 years after it was founded.
Orochem is headquartered in Naperville, United States. It is registered at Naperville, Illinois, United States.
Orochem has 21 employees.
The primary company behind Orochem, Orochem (India) Private Limited, reported revenue of βΉ8.15 Cr for FY 2025, up 2% year on year.
Orochem develops and manufactures products for biomolecular separation and purification for industrial and research applications. The company was established in 1996 to manufacture products for bioanalysis, drug discovery, genomics and proteomics applications involving separation and purification of biomolecules. The company has a sizeable, and growing portfolio of products covering bioanalytical sample preparation and analysis, chromatography, simulated moving bed chromatography for purification of biochemicals and organic compounds, and proteomics. The company also manufactures positive pressure processors, vacuum manifolds and robotic liquid handling systems for laboratory automation and high-throughput lab processes. In 2006, Orochem acquired Column Engineering Inc to provide full-service silica manufacturing for analytical and preparatory chromatography. The company also offers CMO services for industrial scale purification of APIs, nutritional supplements, fatty acids, and speciality sugars.
Orochem's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Orochem has 1 investor. Key investors include HHS.
Orochem operates through Orochem (India) Private Limited.
The legal entities of Orochem currently have 5 directors, including Vedbhushan Dharambir Gulati, Asha A Oroskar, Anil Rajaram Oroskar and others.